Associations - ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3)

ERBB3 overexpression	Colorectal Cancer	ERBB3 overexpression	Colorectal Cancer	panitumumab Sensitive: B - Late Trials panitumumab Sensitive : B	panitumumab Sensitive: B - Late Trials panitumumab Sensitive : B
ERBB3 expression	HER2 Positive Breast Cancer	ERBB3 expression	HER2 Positive Breast Cancer	ado-trastuzumab emtansine Sensitive: B - Late Trials ado-trastuzumab emtansine Sensitive : B	ado-trastuzumab emtansine Sensitive: B - Late Trials ado-trastuzumab emtansine Sensitive : B
ERBB3-L	Squamous Cell Carcinoma of Head and Neck	ERBB3-L	Squamous Cell Carcinoma of Head and Neck	afatinib Sensitive: B - Late Trials afatinib Sensitive : B	afatinib Sensitive: B - Late Trials afatinib Sensitive : B
ERBB3 expression	Colorectal Cancer	ERBB3 expression	Colorectal Cancer	U3-1402 Sensitive: C2 – Inclusion Criteria U3-1402 Sensitive : C2	U3-1402 Sensitive: C2 – Inclusion Criteria U3-1402 Sensitive : C2
ERBB3 expression	Breast Cancer	ERBB3 expression	Breast Cancer	U3-1402 Sensitive: C2 – Inclusion Criteria U3-1402 Sensitive : C2	U3-1402 Sensitive: C2 – Inclusion Criteria U3-1402 Sensitive : C2
ERBB3 expression + CD73 expression	Colorectal Cancer	ERBB3 expression + CD73 expression	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
ERBB3 mutation	Gallbladder Cancer	ERBB3 mutation	Gallbladder Cancer	lapatinib Sensitive: C3 – Early Trials lapatinib Sensitive : C3	lapatinib Sensitive: C3 – Early Trials lapatinib Sensitive : C3
ERBB3 expression	Colorectal Cancer	ERBB3 expression	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
ERBB3 mutation	Gallbladder Cancer	ERBB3 mutation	Gallbladder Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
ERBB3 amplification	Gallbladder Cancer	ERBB3 amplification	Gallbladder Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
ERBB3 amplification + ERBB3 mutation	Gallbladder Cancer	ERBB3 amplification + ERBB3 mutation	Gallbladder Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
ERBB3 underexpression	Colorectal Cancer	ERBB3 underexpression	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3

ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3)

Associations(64)

Associations
(64)